05:54 PM EDT, 04/03/2024 (MT Newswires) -- Aquestive Therapeutics ( AQST ) on Wednesday filed a registration statement with the US Securities and Exchange Commission covering the potential sale of up to $250 million of its securities from time to time in one or more offerings.

The filing covers common and preferred stock, debt securities, warrants, rights and units.

The company intends to use the proceeds from the sale for working capital, capital expenditures, general corporate purposes and to invest in or acquire businesses or technologies.

Price: 4.1, Change: -0.28, Percent Change: -6.39